The Theme Code "微生物、その培養処理技術" had 214 patent application filings in the most recent period (2023-01-01 to 2023-03-31). This is a significantly decreased of -676 filings (-76.0%) over 890 they had in the same period of the previous year (2022-01-01 to 2022-03-31).
The highest number of filings in 2019 with 4,784 cases, and their lowest number in 2022 with 3,308 cases.
The mean of the number of filings over the last 5 years (2018 to 2023, 20,779 cases in total) is 3,463, and the median is 3,828. The coefficient of variation (standard deviation/mean) is 0.4, and there have been big fluctuations in the number of filings from year to year.
Index | Value |
---|---|
Average | 3,463 patents |
Std Dev | 1,448 |
COV | 0.4 |
Year | Cases | YOY |
---|---|---|
2022 year | 3,308 cases | -12.14 % |
2021 year | 3,765 cases | -3.24 % |
2020 year | 3,891 cases | -18.67 % |
This report provides the latest patent analysis information (the IP landscape, including a patent map) on the patent search results of the JP patent database for 微生物、その培養処理技術[4B065] for the period of the last 10 years (2014-01-01 to 2024-11-30). You can compare the information in this report with the trends in your competitors’ patent filings and technologies, and use it to search for important patents.
This service provides, free of charge, a patent analysis report based on the latest patent data (Japanese, U.S., European, and PCT application publications) for use in patent searches, patent analysis, and IP landscaping. The service is offered by "Patent Integration" a firm specializing in patent search/patent analysis.
This report includes basic information to help you understand the IP strategy and management of 微生物、その培養処理技術, such as changes in the number of patents/patent applications they have filed, comparisons of the numbers of patents/patent applications filed by their peers and competitors, their top coapplicants (joint research partners, alliance partners), and their most important patents. It can be used in various intellectual property business operations such as IP landscaping, patent search/patent analysis, preparation of intellectual property business evaluation reports, selection of M&A candidates, and selection of alliance partners.
He is a patent attorney at a patent office. He specializes in invention counseling, patent filing, and intellectual property strategies for start-up companies and new businesses in the fields of software, information technology and artificial intelligence. He runs a patent course for beginners on Udemy, an online course provider.
After studying physics at the University of Tokyo as a doctoral student, he was engaged in intellectual property analysis and technology trend research as an in-house patent attorney at a precision equipment manufacturer and at Toyota Central R&D Labs. Inc..
The concept of the "IP landscape" (IPL) has been attracting attention recently.
An IP landscape is not limited to patent information, but also integrates and analyzes business information (e.g., non-patent information such as papers, news releases, stock information, and market information). Intellectual-property-based business management is realized through the analysis of intellectual property information applied to the formulation of management strategies and business strategies. This is a comprehensive approach that includes but not limited to planning of open and closed strategies, selecting M&A candidates, searching for alliance partners, and formulating intellectual property strategies, through the exploitation of intellectual property information.
IP landscaping usually includes patent search and patent analysis. In patent search and patent analysis, it is important to grasp the market position of each company and the overall technological trends and development trends for each technology. More specifically, it is important to understand what intellectual property your own company and other companies hold, what the strengths and weaknesses of other companies are, and how other companies are trying to exploit their intellectual property. In other words, it is important to understand both the business strategy and the intellectual property strategy of each company.
After reading this search report, you may be interested in more detailed patent searches and patent analysis. We offer a service called Patent Integration, which is an integrated patent search and patent analysis service. With reasonable pricing and a simple user interface such that even beginners can quickly search for and analyze patent information by company or technology from a web browser, please consider using it for detailed patent searches, patent analysis, and IP landscaping.
Patent Integration has a patent-landscaping function that can visually represent a set of tens of thousands of patents/patent applications. This allows you to convincingly show the technical positions of your company and its competitors to your management and business strategists in order to formulate management strategies and business strategies.
The changes in the number of patent filings of 微生物、その培養処理技術 over the last 20 years (JP) are shown below.
The change in the number of patents/patent applications is the most basic index in patent analysis. By examining the change in the number of patents/patent applications, you can see the status of technological development and R&D focus for each company or technology. It should be noted that since there is a one and a half year lag between the filing and the laying open of patent applications, it is not possible to analyze the situation more recently than one and half years prior to the present.
In this report, you can only see the change in the number of patents/patent applications by company or technology, whereas Patent Integration allows you to quickly compare the number of patent applications with your competitors in each technical field by cross-referencing with other keywords and patent classifications.
Patent landscaping is a visualization of the distribution of patent filings (application focus areas) for each technical keyword. Mountains and islands indicated by heatmap contours represent clusters of patent applications filed, and red areas on the heatmap indicate many patent filings relating to the keyword.
The patent landscape for 微生物、その培養処理技術 gives an intuitive understanding of what patent filings they have made and what technical position is to be established. By selecting filing year checkboxes and filtering, you can track their past filing trends (what technical area they have focused on).
By selecting applicant/patent holder checkboxes and filtering, you can visually grasp the technical areas of the filings for each applicant and the partnerships or alliances formed. Please use it as a guide for patent analysis and IP landscaping.
In addition, by visually representing the patent data in this manner, you can convincingly show the technical positions of your company and its competitors to your management and business strategists in order to formulate management strategies and business strategies.
In Patent Integration, you can check the specifics of a patent filing by clicking anywhere on the patent landscape screen. You can also quickly check the position of each applicant for each technical field by cross-referencing with other keywords and patent classifications. You can use it as a guide when considering hypotheses about each company's IP strategy on the IP Landscape. You can also use it for higher-grade intellectual property activities. It has reasonable pricing and a simple user interface that is easy for beginners to handle.
The following is a list of words (characteristic terms) often used in 微生物、その培養処理技術 patent applications. Characteristic terms with a higher importance are used in more patents/patent applications.
This patent analysis report was created for a patent search set of 37,339 cases retrieved by applying the following search formula and analysis period to the following patent database. Patent information such as a patent analysis result, a patent map, and a patent landscape can be freely used for patent searches, analysis, and work on intellectual property strategies, including IP landscaping.
The patent information of the higher applicant in the technical theme 微生物、その培養処理技術 is shown below. By comparing the number of patents of each company, you can check the research and development status of each company's past and present technical themes and the position of each company in the technical theme.
Comparing the number of applications of each company, 花王株式会社 has the highest number of joint applications in the last in the last 3 years (2022 to 2024) with 37 cases, followed by ザリージェンツオブザユニバーシティオブカリフォルニア with 32 cases.
Name | Cases |
---|---|
花王株式会社 | 37 cases |
ザリージェンツオブザユニバーシティオブカリフォルニア | 32 cases |
国立研究開発法人産業技術総合研究所 | 22 cases |
株式会社カネカ | 22 cases |
ジェネンテックインコーポレイテッド | 17 cases |
武田薬品工業株式会社 | 12 cases |
国立大学法人京都大学 | 12 cases |
ノバルティスアーゲー | 11 cases |
国立研究開発法人理化学研究所 | 7 cases |
味の素株式会社 | 4 cases |
Comparing the number of applications of each company, ザリージェンツオブザユニバーシティオブカリフォルニア has the highest number of joint applications in the last for the target period (2014 to 2024) with 339 cases, followed by ジェネンテックインコーポレイテッド with 295 cases.
Name | Cases |
---|---|
ザリージェンツオブザユニバーシティオブカリフォルニア | 339 cases |
ジェネンテックインコーポレイテッド | 295 cases |
ノバルティスアーゲー | 287 cases |
国立大学法人京都大学 | 278 cases |
国立研究開発法人産業技術総合研究所 | 215 cases |
花王株式会社 | 192 cases |
国立研究開発法人理化学研究所 | 183 cases |
株式会社カネカ | 181 cases |
味の素株式会社 | 136 cases |
武田薬品工業株式会社 | 115 cases |
国立研究開発法人科学技術振興機構 | 30 cases |
Below is a patent map showing changes in the number of applications for JP patents of 11 companies in the same industry over the past 20 years.
The patent information of the higher applicant in the technical theme 微生物、その培養処理技術 is shown below. By comparing the number of patents of each company, you can check the research and development status of each company's past and present technical themes and the position of each company in the technical theme.
among the top coapplicants, 花王株式会社 has the highest number of joint applications in the last in the last 3 years (2022 to 2024) with 37 cases, followed by ザリージェンツオブザユニバーシティオブカリフォルニア with 32 cases.
Name | Cases |
---|---|
花王株式会社 | 37 cases |
ザリージェンツオブザユニバーシティオブカリフォルニア | 32 cases |
国立研究開発法人産業技術総合研究所 | 22 cases |
ジェネンテックインコーポレイテッド | 17 cases |
武田薬品工業株式会社 | 12 cases |
味の素株式会社 | 4 cases |
among the top coapplicants, ザリージェンツオブザユニバーシティオブカリフォルニア has the highest number of joint applications in the last for the target period (2014 to 2024) with 339 cases, followed by ジェネンテックインコーポレイテッド with 295 cases.
Name | Cases |
---|---|
ザリージェンツオブザユニバーシティオブカリフォルニア | 339 cases |
ジェネンテックインコーポレイテッド | 295 cases |
国立研究開発法人産業技術総合研究所 | 215 cases |
花王株式会社 | 192 cases |
味の素株式会社 | 136 cases |
武田薬品工業株式会社 | 115 cases |
国立研究開発法人科学技術振興機構 | 30 cases |
Below is a ranking of the number of JP patent applications by 微生物、その培養処理技術’s top 7 coapplicants over the last 20 years.
Below is a patent map showing the changes in the numbers of JP patent filings by 微生物、その培養処理技術’s top 7 coapplicants over the last 20 years.
微生物、その培養処理技術 filed 295 joint applications with ジェネンテックインコーポレイテッド for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 90 cases in total) is 15.0, and the median is 17.0. The coefficient of variation (standard deviation/mean) is 0.5, and there have been big fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2015 with 63 cases, and their lowest number in 2020 with 14 cases.
Index | Value |
---|---|
Average | 15.0 patents |
Std Dev | 7.3 |
COV | 0.5 |
Year | Cases | YOY |
---|---|---|
2022 year | 17 cases | -29.17 % |
2021 year | 24 cases | +71.4 % |
2020 year | 14 cases | -22.22 % |
微生物、その培養処理技術 filed 215 joint applications with 国立研究開発法人産業技術総合研究所 for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 100 cases in total) is 16.7, and the median is 16.0. The coefficient of variation (standard deviation/mean) is 0.4, and there have been big fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2014 with 37 cases, and their lowest number in 2022 with 15 cases.
Index | Value |
---|---|
Average | 16.7 patents |
Std Dev | 6.5 |
COV | 0.4 |
Year | Cases | YOY |
---|---|---|
2022 year | 15 cases | -11.76 % |
2021 year | 17 cases | +13.33 % |
2020 year | 15 cases | -21.05 % |
微生物、その培養処理技術 filed 136 joint applications with 味の素株式会社 for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 52 cases in total) is 8.7, and the median is 6.0. The coefficient of variation (standard deviation/mean) is 0.8, and there have been relatively large fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2016 with 24 cases, and their lowest number in 2022 with 0 cases.
Index | Value |
---|---|
Average | 8.7 patents |
Std Dev | 7.1 |
COV | 0.8 |
Year | Cases | YOY |
---|---|---|
2022 year | 0 cases | -100 % |
2021 year | 4 cases | -50.0 % |
2020 year | 8 cases | -60.0 % |
微生物、その培養処理技術 filed 115 joint applications with 武田薬品工業株式会社 for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 78 cases in total) is 13.0, and the median is 13.5. The coefficient of variation (standard deviation/mean) is 0.6, and there have been big fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2019 with 23 cases, and their lowest number in 2014 with 2 cases.
Index | Value |
---|---|
Average | 13.0 patents |
Std Dev | 7.4 |
COV | 0.6 |
Year | Cases | YOY |
---|---|---|
2022 year | 12 cases | +33.3 % |
2021 year | 9 cases | -40.0 % |
2020 year | 15 cases | -34.8 % |
微生物、その培養処理技術 filed 30 joint applications with 国立研究開発法人科学技術振興機構 for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 11 cases in total) is 1.8, and the median is 1.0. The coefficient of variation (standard deviation/mean) is 1.1, and there have been very big fluctuations in the number of filings from year to year.
The highest number of filings in 2015 with 6 cases, and their lowest number in 2022 with 0 cases.
Index | Value |
---|---|
Average | 1.8 patents |
Std Dev | 2.0 |
COV | 1.1 |
Year | Cases | YOY |
---|---|---|
2020 year | 4 cases | +100 % |
2019 year | 2 cases | -60.0 % |
2018 year | 5 cases | +25.00 % |
The following shows JP patents held by 微生物、その培養処理技術 that have had an invalidation trial against them demanded or an opposition filed against them by a third party, and 微生物、その培養処理技術’s JP patents/patent applications of high importance cited by Examiners in patent examination processes.
By noting the most important patents, you can obtain knowledge of the competitive business environment in which 微生物、その培養処理技術 is placed (e.g., whether it is a fiercely competitive environment or an oligopolistic market and the like). In general, it can be understood that a company with a large number of demands for invalidation trials is developing their business in a business environment where IP disputes are common.
If you want to search for more detailed information, you can use Patent Integration to retrieve and download by company cited patents/patent applications or patents undergoing invalidation trials. You can quickly extract important patents from a patent set that includes multiple competitors by cross-referencing with other keywords and patent classifications. Please consider using it for searches for important patents/patent applications.
In the last 3 years (2021-12-01 ~ 2024-11-30), there were 6 patents Invalidation Trial from third parties. The average number of Invalidation Trial is 1.2 times. The most recently Invalidation Trial patent is 特許6814997 "5’キャップ付RNAを合成するための組成物および方法" (Invalidation Trial day 2024-05-15) , next is 特許6300215 "植物の特性を増強する方法" (Invalidation Trial day 2023-02-03) .
- | No. | Title | Invalidation Trial days |
---|---|---|---|
1 | 特許6814997 | 5’キャップ付RNAを合成するための組成物および方法 | 2024-05-15 |
2 | 特許6300215 | 植物の特性を増強する方法 | 2023-02-03 |
3 | 特許6896700 | ワクチン組成物 | 2023-01-27 |
4 | 特許6278598 | 細胞傷害誘導治療剤 | 2022-03-31 |
5 | 特許6773929 | 細胞傷害誘導治療剤 | 2022-03-31 |
6 | 特許6692856 | RNA依存性標的DNA修飾およびRNA依存性転写調節のための方法および組成物 | 2022-02-25 |
Of the patent applications filed in the last 10 years (2014-12-01 to 2024-11-30), 4 patents/patent applications were invalidation trial more than once in the examination process of other patent applications. The mean of the number of invalidation trial is 1.2. The most invalidation trial patent is 特許6300215 "植物の特性を増強する方法" (2 times) , and the next most invalidation trial patent is 特許6814997 "5’キャップ付RNAを合成するための組成物および方法" (1 times) .
- | No. | Title | |
---|---|---|---|
1 | 特許6300215 | 植物の特性を増強する方法 | 2 times |
2 | 特許6814997 | 5’キャップ付RNAを合成するための組成物および方法 | 1 times |
3 | 特許6554730 | ビフィドバクテリウム・ロンガム及び海馬BDNF発現 | 1 times |
4 | 特許6896700 | ワクチン組成物 | 1 times |
In the last 3 years (2021-12-01 ~ 2024-11-30), there were 39 patents Opposition from third parties. The average number of Opposition is 1.0 times. The most recently Opposition patent is 特許7468955 "細胞の培養上清を生産する方法" (Opposition day 2024-10-01) , next is 特許7456381 "幹細胞の培養用添加物および培養用培地、ならびに培養方法" (Opposition day 2024-09-27) .
- | No. | Title | Opposition days |
---|---|---|---|
1 | 特許7468955 | 細胞の培養上清を生産する方法 | 2024-10-01 |
2 | 特許7456381 | 幹細胞の培養用添加物および培養用培地、ならびに培養方法 | 2024-09-27 |
3 | 特許7492074 | 球状藻体の製造方法 | 2024-09-11 |
4 | 特許7438604 | SARS-COV-2 mRNAドメインワクチン | 2024-08-23 |
5 | 特許7433217 | RNAウイルスの処理方法 | 2024-08-15 |
6 | 特許7471069 | 移植片の活性を高める方法 | 2024-08-15 |
7 | 特許7433800 | 麹菌の液体組織培養物の製造および利用方法 | 2024-08-06 |
8 | 特許7425092 | 抗線維化剤、及び抗線維化作用を有する細胞外小胞の製造方法 | 2024-07-29 |
9 | 特許7427180 | 毛包原基及びその製造方法 | 2024-06-25 |
10 | 特許7448953 | 眼疾患のための細胞モデル及び治療関連出願への相互参照 | 2024-04-17 |
In the last 3 years (2021-12-01 ~ 2024-11-30), there were 90 patents Protest from third parties. The average number of Protest is 1.4 times. The most recently Protest patent is 特開2022-126707 "ドコサヘキサエン酸含有油及びその製造方法" (Protest day 2024-11-08) , next is 特表2021-522805 "hMPCの集団をゼノフリー生成するための方法" (Protest day 2024-11-08) .
- | No. | Title | Protest days |
---|---|---|---|
1 | 特開2022-126707 | ドコサヘキサエン酸含有油及びその製造方法 | 2024-11-08 |
2 | 特表2021-522805 | hMPCの集団をゼノフリー生成するための方法 | 2024-11-08 |
3 | 特開2023-005522 | 浸透圧調節剤 | 2024-11-05 |
4 | 特開2023-153942 | フィブロイン様タンパク質の製造法 | 2024-11-01 |
5 | 特開2021-126061 | 新規乳酸菌用培地 | 2024-10-11 |
6 | 特開2021-185857 | 高温耐性スジアオノリ及びその生産方法 | 2024-09-27 |
7 | 特表2024-530279 | 流体フロープレート | 2024-09-18 |
8 | 特開2024-054301 | シート状細胞培養物の製造方法 | 2024-09-04 |
9 | 特開2024-099681 | 粒子、粒子含有組成物および粒子の製造方法 | 2024-08-30 |
10 | 特開2021-132601 | 油脂酵母の油脂生産制御因子 | 2024-08-20 |
11 | 特開2023-025510 | 積層膜 | 2024-07-17 |
12 | 特開2021-122277 | 結合組織体形成用構造集合体および結合組織体の形成方法 | 2024-06-28 |
13 | 特開2024-073718 | 微生物検出用の培地、及び当該培地を用いる微生物の検出方法 | 2024-06-20 |
14 | 特許7513305 | 3次元培養された幹細胞から細胞外小胞体を製造する方法 | 2024-05-02 |
15 | 特表2022-513628 | クモ糸タンパク質のアルカリ精製法 | 2024-04-25 |
16 | 特開2023-022363 | 細胞保護用剤 | 2024-04-18 |
17 | 特開2021-136898 | アルコール発酵醪の管理方法、アルコール発酵醪の管理プログラム、及びアルコール発酵醪の管理装置、並びに酒類の製造方法 | 2024-04-02 |
18 | 特開2022-135037 | エルゴチオネイン高含有麹菌固体発酵物、並びにその製造方法 | 2024-03-28 |
19 | 特許7495360 | バッグセット | 2024-03-23 |
20 | 特開2023-175938 | 糖代謝改善用組成物 | 2024-03-04 |
Of the patent applications filed in the last 10 years (2014-12-01 to 2024-11-30), 197 patents/patent applications were protest more than once in the examination process of other patent applications. The mean of the number of protest is 1.3. The most protest patent is 特許7128530 "油脂含有排水処理方法、システムおよび装置" (6 times) , and the next most protest patent is 特許7101362 "1,2-ジヒドロキシ-5-(メチルスルフィニル)ペンタン-3-オンの生成能が低い酵母の作出方法" (6 times) .
- | No. | Title | |
---|---|---|---|
1 | 特許7128530 | 油脂含有排水処理方法、システムおよび装置 | 6 times |
2 | 特許7101362 | 1,2-ジヒドロキシ-5-(メチルスルフィニル)ペンタン-3-オンの生成能が低い酵母の作出方法 | 6 times |
3 | 特開2018-199631 | ビフィズス菌含有カプセル製剤 | 4 times |
4 | 特許7477973 | 脱窒処理方法および脱窒処理装置 | 4 times |
5 | 再公表2017/094804 | ドコサヘキサエン酸含有油及びその製造方法 | 4 times |
In the last 3 years (2021-12-01 ~ 2024-11-30), there were 535 patents Inspection from third parties. The average number of Inspection is 1.4 times. The most recently Inspection patent is 特表2022-547154 "調節可能な制御のためのCA2-IL15融合タンパク質" (Inspection day 2024-11-25) , next is 特表2021-522805 "hMPCの集団をゼノフリー生成するための方法" (Inspection day 2024-11-25) .
- | No. | Title | Inspection days |
---|---|---|---|
1 | 特表2022-547154 | 調節可能な制御のためのCA2-IL15融合タンパク質 | 2024-11-25 |
2 | 特表2021-522805 | hMPCの集団をゼノフリー生成するための方法 | 2024-11-25 |
3 | 特表2022-516318 | カプセル化ポリヌクレオチド及び使用方法 | 2024-11-22 |
4 | 特表2022-514116 | 新規な癌抗原及び方法 | 2024-11-21 |
5 | 特許6231007 | BCMAおよびCD3に対する結合分子 | 2024-11-15 |
6 | 特許7250736 | BCMAおよびCD3に対する結合分子 | 2024-11-15 |
7 | 特許7194240 | 抗BCMA抗体、BCMA及びCD3に結合する二重特異性抗原結合分子、並びにそれらの使用 | 2024-11-15 |
8 | 特許6378087 | BCMAおよびCD3に対する結合分子 | 2024-11-15 |
9 | 特開2017-195889 | BCMAおよびCD3に対する結合分子 | 2024-11-15 |
10 | 特開2023-027228 | 抗BCMA抗体、BCMA及びCD3に結合する二重特異性抗原結合分子、並びにそれらの使用 | 2024-11-15 |
11 | 特表2018-525005 | 抗BCMA抗体、BCMA及びCD3に結合する二重特異性抗原結合分子、並びにそれらの使用 | 2024-11-15 |
12 | 特開2022-008533 | カゼインを含む組成物およびこれを作製する方法 | 2024-11-15 |
13 | 特表2022-513077 | クロストリジウム・ディフィシル多成分ワクチン | 2024-11-12 |
14 | 特許7513305 | 3次元培養された幹細胞から細胞外小胞体を製造する方法 | 2024-11-12 |
15 | 特表2021-526372 | 有機体成長およびフェージングのための中規模モデル | 2024-11-12 |
16 | 特開2023-005522 | 浸透圧調節剤 | 2024-11-07 |
17 | 特表2024-512769 | 抗原特異的T細胞を生成し、疾患を治療するための材料及び方法 | 2024-11-06 |
18 | 特開2023-123469 | B型肝炎ウイルス感染のためのRNAi薬 | 2024-11-06 |
19 | 特表2022-504139 | バイオフィルムの除去のためのHMGB1タンパク質誘導体 | 2024-11-05 |
20 | 特開2019-030338 | BCMA発現に相関性を有する疾患を治療する因子及び方法 | 2024-11-01 |
Of the patent applications filed in the last 10 years (2014-12-01 to 2024-11-30), 1,049 patents/patent applications were inspection more than once in the examination process of other patent applications. The mean of the number of inspection is 1.3. The most inspection patent is 特許6320473 "アロNKT細胞を用いた免疫療法およびそのためのT細胞抗原受容体(TCR)遺伝子のα鎖領域が均一なVα−Jαに再構成されている細胞および該細胞由来NKT細胞のバンキング" (48 times) , and the next most inspection patent is 特許7433800 "麹菌の液体組織培養物の製造および利用方法" (14 times) .
- | No. | Title | |
---|---|---|---|
1 | 特許6320473 | アロNKT細胞を用いた免疫療法およびそのためのT細胞抗原受容体(TCR)遺伝子のα鎖領域が均一なVα−Jαに再構成されている細胞および該細胞由来NKT細胞のバンキング | 48 times |
2 | 特許7433800 | 麹菌の液体組織培養物の製造および利用方法 | 14 times |
3 | 特開2015-107131 | ADAM6マウス | 12 times |
4 | 再公表2019/172112 | 細胞凍結保存用溶液およびその利用 | 10 times |
5 | 再公表2017/094804 | ドコサヘキサエン酸含有油及びその製造方法 | 9 times |
Of the patent applications filed in the last 10 years (2014-12-01 to 2024-11-30), 4,775 patents/patent applications were cited more than once in the examination process of other patent applications. The mean of the number of cited is 2.2. The most cited patent is 特許6395765 "配列操作のための改善された系、方法および酵素組成物のエンジニアリングおよび最適化" (36 times) , and the next most cited patent is 特許6196343 "免疫グロブリンに特異的に結合するタンパク質および免疫グロブリン結合性アフィニティーリガンド" (36 times) .
- | No. | Title | |
---|---|---|---|
1 | 特許6395765 | 配列操作のための改善された系、方法および酵素組成物のエンジニアリングおよび最適化 | 36 times |
2 | 特許6196343 | 免疫グロブリンに特異的に結合するタンパク質および免疫グロブリン結合性アフィニティーリガンド | 36 times |
3 | 特許6352974 | ワクチンのための高力価組み換えインフルエンザ・ウィルス | 28 times |
4 | 特許6375329 | ベロ細胞において増強された複製を有する高力価の組換えインフルエンザウイルス | 25 times |
5 | 特許6731346 | 標的TGFβ阻害 | 24 times |
"Patent Integration Report" is a web service provided by "Patent Integration Co., Ltd." operated by patent attorneys who are experts in intellectual property rights. Based on the latest patent data, this is one of the largest patent report services in Japan that provides information on technology trends in various companies and technology fields.
The purpose of this web service is to make intellectual property information familiar to many people, regardless of whether they have an interest in intellectual property rights, and to make use of it.
We actively provide various types of patent information that can be used in various media articles such as newspapers, magazines, and web media. Please feel free to contact us from "Inquiry form for details on the content of patent information that can be provided, conditions for provision, etc. Please contact us.
All rights related to the data, documents and charts belong to "an integrated patent search/analysis service provider, Patent Integration". Please specify the source “Patent Integration Report, URL: https://patent-i.com/report/en/" when inserting them into in-house materials, external report materials, etc., regardless of whether they are paid or free of charge.
Patent data is obtained by aggregating and analyzing the latest patent data issued by the Patent Offices of respective countries and jurisdictions and by WIPO. Although we take great care in publishing and analyzing the results, we do not guarantee the correctness of the data. We appreciate your understanding.
If you have any concerns about this service, please feel free to contact us.
All rights to the data, documents, figures and tables are reserved by e-Patent. When publishing internal documents, external reports, etc. (whether paid or free of charge), please use the following URL: https://e-patent.co.jp/.
e-Patent will not be liable for any damages or losses arising from the use of the global patent application status, ranking information, or population search formula in the "SDGs Global Company Ranking from a Patent Perspective". Items with ● in front of the target are not supported at this time (judged to be difficult to approach from the patent information analysis).
There is no problem to cite patent application status and ranking information, but please clearly indicate "Source: e-Patent Co.
Credit notation
・MeCab user dictionary for science technology term © National Bioscience Database Center licensed under CC Attribution-Share Alike 4.0 International